Stocks and Investing
Stocks and Investing
Wed, October 16, 2013
[ 12:00 AM ] - WOPRAI
Tue, October 15, 2013
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, October 14, 2013
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, October 11, 2013
[ 12:00 AM ] - WOPRAI
Thu, October 10, 2013
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, October 9, 2013
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, October 8, 2013
Vamil Divan Initiated (ABBV) at Buy and Held Target at $54 on, Oct 8th, 2013
Vamil Divan of Credit Suisse, Initiated "AbbVie Inc." (ABBV) at Buy and Held Target at $54 on, Oct 8th, 2013.
Vamil has made no other calls on ABBV in the last 4 months.
There is 1 other peer that has a rating on ABBV. Out of the 1 peers that are also analyzing ABBV, 0 agree with Vamil's Rating of Hold.
This is the rating of the analyst that currently disagrees with Vamil
- David Toung of "Argus Research" Initiated at Strong Buy on, Monday, August 12th, 2013